P. Lalonde

发表

The cognitive and anatomo-functional basis of reality distortion in schizophrenia: A view from memory event-related potentials

F. Guillem, M. Bicu, T. Pampoulova, 2003, Psychiatry Research.

Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study

E. Stip, P. Lalonde, A. Mendrek, 2013, Psychiatry Research: Neuroimaging.

Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test.

C. Benkelfat, S. Lal, D. Bloom, 2002, Archives of general psychiatry.

Dopamine Beta‐Hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study

Kenji Yamamoto, Pierre Lalonde, Joel Gelernter, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

The Neural Correlates of Mental Rotation Abilities in Cannabis-Abusing Patients with Schizophrenia: An fMRI Study

Adrianna Mendrek, Pierre Lalonde, Emmanuel Stip, 2013, Schizophrenia research and treatment.

[Implementation of the multi-site Integrated Psychological Treatment (IPT) program for people with schizophrenia. Elaboration of renewed version].

E. Stip, P. Lalonde, A. Lesage, 2005, Sante mentale au Quebec.

Schizophrenia, An Illness with Bad Outcome: Myth or Reality?

P. Lalonde, A. Lesage, L. Nicole, 2011, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial

R. Godbout, E. Stip, F. Guillem, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images

E. Stip, P. Lalonde, O. Lungu, 2017, Front. Psychiatry.

Evaluating antipsychotic medications: predictors of clinical effectiveness. Report of an expert review panel on efficacy and effectiveness.

P. Lalonde, 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Clozapine: Current Status and Role in the Pharmacotherapy of Schizophrenia

G. Remington, P. Lalonde, B. Jones, 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Reduced dorsolateral prefrontal cortex activation during affective Go/NoGo in violent schizophrenia patients: An fMRI study

P. Lalonde, O. Lungu, S. Richard-Devantoy, 2017, Schizophrenia Research.

Polyglutamine-containing proteins in schizophrenia

Í. Lopes-Cendes, C. Benkelfat, S. Lal, 1999, Molecular Psychiatry.

Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia.

M. Alda, C. Benkelfat, S. Lal, 1999, American journal of medical genetics.

T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.

M. Alda, C. Benkelfat, S. Lal, 1999, Journal of psychiatry & neuroscience : JPN.

Clozapine in the Treatment of Refractory Schizophrenia: Canadian Policies and Clinical Guidelines*

P. Lalonde, B. Jones, D. Addington, 1992, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[The family of the schizophrenic : interfering or ally?].

P. Lalonde, L. Boucher, 1982, Sante mentale au Quebec.

[Treatment of schizophrenia: a new synthesis of the literature].

P. Lalonde, P. Sidoun, 1988, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Lower Incidence and Increased Male: Female Ratio in Schizophrenia

P. Lalonde, A. Lesage, L. Nicole, 1992, British Journal of Psychiatry.

Working memory and depressive symptoms in patients with schizophrenia and substance use disorders

E. Stip, T. Pampoulova, P. Lalonde, 2008, Cognitive neuropsychiatry.

Long term course and outcome of first episode schizophrenia: a 27-to-31-year follow-up

P. Lalonde, A. Lesage, A. Abdel-Baki, 2021, Social Psychiatry and Psychiatric Epidemiology.

Health care resource use associated with integrated psychological treatment.

E. Stip, P. Lalonde, A. Lesage, 2006, The journal of mental health policy and economics.

Teaching Therapeutic Skills of a Psychological Nature to Future Physicians

P. Lalonde, F. Borgeat, J. Gagnon, 1985, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Are there common mechanisms in sensation seeking and reality distortion in schizophrenia? A study using memory event-related potentials

E. Stip, F. Guillem, T. Pampoulova, 2005, Psychiatry Research.

The relationships between symptom dimensions and dysphoria in schizophrenia

E. Stip, F. Guillem, T. Pampoulova, 2005, Schizophrenia Research.

Changes in the neuropsychological correlates of clinical dimensions between the acute and stable phase of schizophrenia

E. Stip, F. Guillem, T. Pampoulova, 2005, Brain and Cognition.

Analysis of 14 CAG repeat-containing genes in schizophrenia.

A Labelle, M. Alda, C. Benkelfat, 1999, American journal of medical genetics.

Benefits and Risks of Antipsychotic Polypharmacy

E. Stip, P. Lalonde, L. Nicole, 2008, Drug safety.

Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue

R. Godbout, E. Stip, B. Jemel, 2022, Nature Communications.

[Clozapine and pregnancy].

P. Lalonde, H. Nguyen, H. Nguyen, 2003, L'Encephale.

Patients versus Rehabilitation Practitioners: A Comparison of Assessments of Needs for Care

P. Lalonde, A. Lesage, G. Comtois, 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophrenia

C. Benkelfat, S. Lal, R. Rozen, 2000, Molecular Psychiatry.

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders

P. Lalonde, A. Malla, A. Labelle, 2005, Neuropsychiatric disease and treatment.

DRD3 and DAT1 genes in schizophrenia: an association study.

C. Benkelfat, S. Lal, D. Bloom, 2000, Journal of psychiatric research.

Evidence review and clinical guidance for the use of ziprasidone in Canada

V. Taylor, P. Lalonde, A. Malla, 2013, Annals of General Psychiatry.

Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings

E. Stip, P. Lalonde, O. Lungu, 2016, Schizophrenia Research.

Clozapine and visuospatial processing in treatment-resistant schizophrenia

E. Stip, P. Lalonde, A. Mendrek, 2013, Cognitive neuropsychiatry.

Cognitive predictors of psychosocial functioning outcome in schizophrenia: A follow-up study of subjects participating in a rehabilitation program

E. Stip, P. Lalonde, A. Lesage, 2005, Schizophrenia Research.

The crucial role of sustained attention in community functioning in outpatients with schizophrenia

E. Stip, P. Lalonde, A. Lesage, 2004, Psychiatry Research.

Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers

C. Benkelfat, S. Lal, R. Palmour, 2002, Schizophrenia Research.

Polymorphism in the cell division cycle 45 like gene and schizophrenia.

C. Benkelfat, D. Bloom, P. Lalonde, 2001, American journal of medical genetics.

Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment

E. Stip, P. Lalonde, O. Lungu, 2012, Translational Psychiatry.

Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization.

E. Stip, T. Pampoulova, P. Lalonde, 2008, Journal of psychiatric research.

Burden of care of families not living with young schizophrenic relatives.

P. Lalonde, A. Lesage, N. Carpentier, 1992, Hospital & community psychiatry.

Avatar Therapy for Persistent Auditory Verbal Hallucinations in an Ultra-Resistant Schizophrenia Patient: A Case Report

P. Lalonde, S. Potvin, Laura Dellazizzo, 2018, Front. Psychiatry.

Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients

Pierre Lalonde, C. Benkelfat, S. Lal, 2005, Schizophrenia Research.

Use of the process dissociation procedure to study the contextual effects on face recognition in schizophrenia: Familiarity, associative recollection and discriminative recollection

G. Tiberghien, E. Stip, F. Guillem, 2007, Psychiatry Research.

Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial

K. O'Connor, P. Lalonde, P. Renaud, 2018, Schizophrenia Research.

Preserved awareness of their cognitive deficits in patients with schizophrenia: Convergent validity of the SSTICS

E. Stip, P. Lalonde, A. Lesage, 2009, Schizophrenia Research.

E. Stip, P. Lalonde, O. Lungu, 2019, Psychiatry Research: Neuroimaging.

CANTAB explicit memory is less impaired in addicted schizophrenia patients

E. Stip, P. Lalonde, S. Potvin, 2005, Brain and Cognition.

Neuronal correlates of appetite regulation in patients with schizophrenia: Is there a basis for future appetite dysfunction?

E. Stip, P. Lalonde, O. Lungu, 2013, European Psychiatry.

Association between the methylenetetrahydrofolate reductase 677C-->T missense mutation and schizophrenia.

C. Benkelfat, S. Lal, R. Rozen, 2000, Molecular psychiatry.

[From symptomatology to problem-solving : an integrated approach for people with schizophrenia.].

P. Lalonde, C. Briand, C. Morin, 1999, Sante mentale au Quebec.

Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program

E. Stip, P. Lalonde, L. Nicole, 2004, Schizophrenia Research.

Differential Effects of D2- and D4-Blocking Neuroleptics on the Procedural Learning of Schizophrenic Patients

E. Stip, M. Bédard, P. Lalonde, 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.